We surveyed IP, R&D and Innovation professionals from around the world to better understand how sentiments towards innovation have changed in light of COVID-19.
Friday, June 26, 2020
Applying AI machine learning to scientific patent documents, journals and data is the next frontier in valuable innovation insights.
Tuesday, March 10, 2020
Strategic partnership unites scientific content and AI-powered technology to accelerate global innovation.
Tuesday, March 10, 2020
Use connected innovation intelligence to separate signals from noise and hone-in on only the most relevant sequences and patents for your research.
Friday, November 8, 2019
What are all the startups applying artificial intelligence in drug discovery currently? ...
Monday, September 30, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Thursday, August 29, 2019
PatSnap, the world’s leading provider of research and development (R&D) analytics, has announced the launch of PatSnap Bio, a new module to the PatSnap platform.
Thursday, August 29, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Thursday, August 29, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Thursday, August 29, 2019
Creating life from deadly bacteria and using the human immune system in the fight against cancer?
Thursday, August 29, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Wednesday, August 28, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Wednesday, August 28, 2019
PatSnap has announced the launch of PatSnap Bio, a new module to the PatSnap platform that enables organisations working ...
Wednesday, August 28, 2019
Pfizer recently signed an agreement with Teva Pharmaceuticals, in which Teva can begin to market the US’ first generic version of the drug from December 2017.
Monday, September 11, 2017
The CRISPR/Cas9 gene editing technique has been lauded as one of the most significant advances in medicine, science even, in a generation.
Monday, March 13, 2017
Although biotech and pharma both produce drugs, they do so in different ways and have a different basis.
Wednesday, January 11, 2017